Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Elyssa N Denault"'
Autor:
Andrew A. Davis, Lorenzo Gerratana, Katherine Clifton, Arielle J. Medford, Marko Velimirovic, Whitney L. Hensing, Leslie Bucheit, Ami N. Shah, Paolo D'Amico, Carolina Reduzzi, Qiang Zhang, Charles S. Dai, Elyssa N. Denault, Nusayba A. Bagegni, Mateusz Opyrchal, Foluso O. Ademuyiwa, Ron Bose, William J. Gradishar, Amir Behdad, Cynthia X. Ma, Aditya Bardia, Massimo Cristofanilli
Publikováno v:
EBioMedicine, Vol 86, Iss , Pp 104316- (2022)
Summary: Background: Limited data exist to characterise molecular differences in circulating tumour DNA (ctDNA) for patients with invasive lobular carcinoma (ILC). We analysed metastatic breast cancer patients with ctDNA testing to assess genomic dif
Externí odkaz:
https://doaj.org/article/07b125b3c92b42acba72a92a3f8e5d48
Autor:
Marko Velimirovic, Lorenzo Gerratana, Andrew A Davis, Whitney L Hensing, Katherine Clifton, Ami N Shah, Paolo D'Amico, Charles S Dai, Elyssa N Denault, Cynthia X Ma, Seth A Wander, Dejan Juric, Massimo Cristofanilli, Bruce A Chabner, Aditya Bardia
Publikováno v:
Cancer Research. 82:P2-07
Background: Endocrine therapy with CDK 4/6 inhibitors (ET/CDK4/6i) represents the 1st line therapy for ER+/HER2- ABC. While majority of patients derive clinical benefit with combination therapy, a subset have refractory disease with progression withi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45451e41ea04d68929b99e6bd015bba5
https://doi.org/10.1158/1538-7445.sabcs21-p2-07-02
https://doi.org/10.1158/1538-7445.sabcs21-p2-07-02
Autor:
Martin S. Taylor, Connie Wu, Peter C. Fridy, Stephanie J. Zhang, Yasmeen Senussi, Justina C. Wolters, Wen-Chih Cheng, John Heaps, Bryant D. Miller, Kei Mori, Limor Cohen, Hua Jiang, Kelly R. Molloy, Brian T. Chait, Michael Goggins, Irun Bhan, Joseph W. Franses, Xiaoyu Yang, Mary-Ellen Taplin, Xinan Wang, David C. Christiani, Bruce E. Johnson, Matthew Meyerson, Ravindra Uppaluri, Ann Marie Egloff, Elyssa N. Denault, Laura M. Spring, Tian-Li Wang, Ie-Ming Shih, Euihye Jung, Kshitij S. Arora, Lawrence R. Zukerberg, Osman H. Yilmaz, Gary Chi, Bryanna L. Norden, Yuhui Song, Linda Nieman, Aparna R. Parikh, Matthew Strickland, Ryan B. Corcoran, Tomas Mustelin, George Eng, Ömer H. Yilmaz, Ursula A. Matulonis, Steven J. Skates, Bo R. Rueda, Ronny Drapkin, Samuel J. Klempner, Vikram Deshpande, David T. Ting, Michael P. Rout, John LaCava, David R. Walt, Kathleen H. Burns
Publikováno v:
bioRxiv
Improved biomarkers are needed for early cancer detection, risk stratification, treatment selection, and monitoring treatment response. While proteins can be useful blood-based biomarkers, many have limited sensitivity or specificity for these applic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cdcf66174cd5676ee31b3db57f28b9f
https://hdl.handle.net/11370/41ca3c33-d273-45a6-bf29-9274abc151ef
https://hdl.handle.net/11370/41ca3c33-d273-45a6-bf29-9274abc151ef
Autor:
Vivek Naranbhai, Kerri J. St. Denis, Evan C. Lam, Onosereme Ofoman, Wilfredo F. Garcia-Beltran, Cristhian B. Mairena, Atul K. Bhan, Justin F. Gainor, Alejandro B. Balazs, A. John Iafrate, Ryan J. Sullivan, Aditya Bardia, Laura M. Spring, Steven J. Isakoff, Jocelyn R. Farmer, Leyre Zubiri, Gabriella S. Hobbs, Joan How, Andrew M. Brunner, Amir T. Fathi, Clarie A. Pernat, A. Gavralidis, Jennifer L. Peterson, Mustafa Sakhi, Grace Hambelton, Elyssa N. Denault, Lindsey J. Mortensen, Lailoo A. Periello, Marissa N. Bruno, M.N. Bruno, Brittany Y. Betraux, Alyssa R. Lawless, Melissa A. Jackson, Elizabeth Niehoff, Claire Barabell, Christain N. Nambu, Erika Nakajima, Thomas Reinecke, Cyndi Bowes, Grace E. Kirkpatrick, Julia C. Thierauf, Kerri Reynolds, Henning Willers, Anand S. Dighe, Rebecca Saff, Kimberley Blumenthal
Publikováno v:
Cancer Cell
Patients with cancer are more likely to have impaired immune responses to SARS-CoV-2 vaccines. We study the breadth of responses against SARS-CoV-2 variants after primary vaccination in 178 patients with a variety of tumor types and after booster dos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bddd27fb8f3e6fc92f09a44339448e7e
http://europepmc.org/articles/PMC8730528
http://europepmc.org/articles/PMC8730528
Autor:
Andrew A Davis, Lorenzo Gerratana, Katherine Clifton, Marko Velimirovic, Whitney L Hensing, Ami N Shah, Paolo D’Amico, Carolina Reduzzi, Qiang Zhang, Charles S Dai, Elyssa N Denault, Nusayba A Bagegni, Mateusz Opyrchal, Foluso O Ademuyiwa, Ron Bose, William J Gradishar, Amir Behdad, Cynthia X Ma, Aditya Bardia, Massimo Cristofanilli
Publikováno v:
Cancer Research. 82:PD14-04
Background:Invasive lobular carcinoma (ILC) is the second most common histology of breast cancer, accounting for approximately 10-15% of cases. Prior studies have demonstrated that loss of E-cadherin, as well as alterations in tissue including CDH1,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c69697f3e5ab5b943cc329b214ed125d
https://doi.org/10.1158/1538-7445.sabcs21-pd14-04
https://doi.org/10.1158/1538-7445.sabcs21-pd14-04